Earnings Per Share, Basic in USD/shares of Mersana Therapeutics, Inc. from Q1 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Mersana Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2016 to Q3 2025.
  • Mersana Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -1.51 USD/shares, a 35.5% increase year-over-year.
  • Mersana Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0 USD/shares.
  • Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -0.56 USD/shares, a 62.2% increase from 2023.
  • Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.48 USD/shares, a 32.1% increase from 2022.
  • Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.18 USD/shares, a 9.54% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 -$2 +$0.83 +35.5% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $0 -$5 +$0.09 +1.82% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $0 $0 $0 -18.8% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $0 $6.90 +$7.04 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$7 -$2 -$2 -569% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$5 -$5 -$4 -955% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$1 $0 +$0.36 +69.2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$1 $0 +$0.29 +67.4% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$1 $0 +$0.26 +42.6% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$2 $0 +$0.08 +14.5% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$2 -$1 +$0.07 +11.9% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$2 $0 +$0.26 +37.7% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 -$2 -$1 +$0.02 +3.18% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$2 -$1 +$0.04 +6.78% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$2 -$1 $0 -18% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$2 -$1 $0 -64.3% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024
Q3 2021 -$2 -$1 $0 -90.9% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$1 -$1 $0 -78.8% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$1 -$1 $0 -42.9% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$1 $0 $0 -23.5% 01 Oct 2020 31 Dec 2020 10-K 26 Feb 2021
Q3 2020 -$1 $0 +$0.02 +5.71% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$1 $0 +$0.03 +8.33% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$1 $0 -$1 -149% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 $0 $0 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 $0 01 Jul 2019 30 Sep 2019 10-K 26 Feb 2021
Q2 2019 $0 +$0.18 +33.3% 01 Apr 2019 30 Jun 2019 10-K 26 Feb 2021
Q1 2019 $0.72 +$1.26 01 Jan 2019 31 Mar 2019 10-K 26 Feb 2021
Q2 2018 -$1 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 -$1 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2016 -$11 $0.07 01 Oct 2016 31 Dec 2016 10-K 28 Mar 2018
Q3 2016 -$5 01 Jul 2016 30 Sep 2016 10-K 28 Mar 2018
Q2 2016 -$3 01 Apr 2016 30 Jun 2016 10-K 28 Mar 2018
Q1 2016 -$4 01 Jan 2016 31 Mar 2016 10-K 28 Mar 2018

Mersana Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 +$0.92 +62.2% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$1 +$0.70 +32.1% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 -$2 +$0.23 +9.54% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$2 -$1 -68.5% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 -$1 -$1 -120% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 -$1 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.